Stoked Bio

Leveraging the power of artificial intelligence to develop new medicines that address unmet clinical needs.

Company Facts

Website

Stoked Bio's licensing of enterololin indicates strong financial potential against rising antimicrobial resistance.

The latest AI intelligence, case studies, and research — delivered to your inbox every week.

Free to read. Unsubscribe anytime.

Claim this profile to manage information and unlock premium features.